BIO-TECHNE Corp Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent
BIO-TECHNE Corp (TECH) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent of -$2.54 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent · last filed 2026-08-24
- BIO-TECHNE Corp other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax, parent for the quarter ending 2026-06-30 was $0.00.
- BIO-TECHNE Corp other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax, parent for the quarter ending 2026-03-31 was -$160.00K.
- BIO-TECHNE Corp other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax, parent for the quarter ending 2025-12-31 was -$711.00K.
- BIO-TECHNE Corp other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax, parent for the quarter ending 2025-09-30 was -$1.67M.
- BIO-TECHNE Corp other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax, parent for fiscal 2026 was -$2.54M.
- BIO-TECHNE Corp other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax, parent for fiscal 2025 was -$5.57M.
- BIO-TECHNE Corp other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax, parent for fiscal 2024 was -$4.76M, a 199.31% decline from fiscal 2023.
- BIO-TECHNE Corp other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax, parent for fiscal 2023 was $4.79M, a 66.39% decline from fiscal 2022.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$160.00K derived: sum of 2 quarters · filed 2026-08-24 | -$871.00K derived: sum of 3 quarters · filed 2026-08-24 | -$2.54M 10-K · filed 2026-08-24 |
| 2026-03-31 | -$160.00K 10-Q · filed 2026-05-06 | -$871.00K derived: sum of 2 quarters · filed 2026-05-06 | -$2.54M 10-Q · filed 2026-05-06 | -$3.32M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-12-31 | -$711.00K 10-Q · filed 2026-02-04 | -$2.38M 10-Q · filed 2026-02-04 | -$3.16M derived: sum of 3 quarters · filed 2026-08-24 | -$4.87M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-09-30 | -$1.67M 10-Q · filed 2025-11-05 | -$2.45M derived: sum of 2 quarters · filed 2026-08-24 | -$4.16M derived: sum of 3 quarters · filed 2026-08-24 | -$4.20M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-06-30 | -$781.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$2.49M derived: sum of 2 quarters · filed 2026-08-24 | -$2.54M derived: sum of 3 quarters · filed 2026-08-24 | -$5.57M 10-K · filed 2026-08-24 |
| 2025-03-31 | -$1.71M 10-Q · filed 2026-05-06 | -$1.76M derived: sum of 2 quarters · filed 2026-05-06 | -$4.79M 10-Q · filed 2026-05-06 | -$5.86M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-12-31 | -$45.00K 10-Q · filed 2026-02-04 | -$3.07M 10-Q · filed 2026-02-04 | -$4.15M derived: sum of 3 quarters · filed 2026-08-24 | -$3.81M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-09-30 | -$3.03M 10-Q · filed 2025-11-05 | -$4.10M derived: sum of 2 quarters · filed 2026-08-24 | -$3.77M derived: sum of 3 quarters · filed 2026-08-24 | -$7.44M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-06-30 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$740.00K derived: sum of 2 quarters · filed 2026-08-24 | -$4.41M derived: sum of 3 quarters · filed 2026-08-24 | -$4.76M 10-K · filed 2026-08-24 |
| 2024-03-31 | $335.00K 10-Q · filed 2025-05-08 | -$3.33M derived: sum of 2 quarters · filed 2025-05-08 | -$3.69M 10-Q · filed 2025-05-08 | -$1.19M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-12-31 | -$3.67M 10-Q · filed 2025-02-06 | -$4.02M 10-Q · filed 2025-02-06 | -$1.53M derived: sum of 3 quarters · filed 2025-08-22 | -$3.24M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-09-30 | -$350.00K 10-Q · filed 2024-11-05 | $2.14M derived: sum of 2 quarters · filed 2025-08-22 | $433.00K derived: sum of 3 quarters · filed 2025-08-22 | -$252.00K derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-06-30 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $783.00K derived: sum of 2 quarters · filed 2025-08-22 | $98.00K derived: sum of 3 quarters · filed 2025-08-22 | $4.79M 10-K · filed 2025-08-22 |
| 2023-03-31 | -$1.71M 10-Q · filed 2024-05-06 | -$2.39M derived: sum of 2 quarters · filed 2024-05-06 | $2.30M 10-Q · filed 2024-05-06 | $4.82M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-12-31 | -$685.00K 10-Q · filed 2024-02-07 | $4.01M 10-Q · filed 2024-02-07 | $6.53M derived: sum of 3 quarters · filed 2024-08-22 | $13.71M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-09-30 | $4.70M 10-Q · filed 2023-11-07 | $7.21M derived: sum of 2 quarters · filed 2024-08-22 | $14.39M derived: sum of 3 quarters · filed 2024-08-22 | $17.27M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-06-30 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $9.70M derived: sum of 2 quarters · filed 2024-08-22 | $12.58M derived: sum of 3 quarters · filed 2024-08-22 | $14.26M 10-K · filed 2024-08-22 |
| 2022-03-31 | $7.18M 10-Q · filed 2023-05-08 | $10.06M derived: sum of 2 quarters · filed 2023-05-08 | $11.74M 10-Q · filed 2023-05-08 | $13.31M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-12-31 | $2.88M 10-Q · filed 2023-02-07 | $4.57M 10-Q · filed 2023-02-07 | $6.14M derived: sum of 3 quarters · filed 2023-08-23 | $7.42M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-09-30 | $1.68M 10-Q · filed 2022-11-07 | $3.25M derived: sum of 2 quarters · filed 2023-08-23 | $4.54M derived: sum of 3 quarters · filed 2023-08-23 | $6.60M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-06-30 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $2.86M derived: sum of 2 quarters · filed 2023-08-23 | $4.92M derived: sum of 3 quarters · filed 2023-08-23 | $7.06M 10-K · filed 2023-08-23 |
| 2021-03-31 | $1.29M 10-Q · filed 2022-05-09 | $3.35M derived: sum of 2 quarters · filed 2022-05-09 | $5.49M 10-Q · filed 2022-05-09 | $6.57M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-12-31 | $2.06M 10-Q · filed 2022-02-07 | $4.20M 10-Q · filed 2022-02-07 | $5.29M derived: sum of 3 quarters · filed 2022-08-24 | -$417.00K derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-09-30 | $2.14M 10-Q · filed 2021-11-08 | $3.23M derived: sum of 2 quarters · filed 2022-08-24 | -$2.48M derived: sum of 3 quarters · filed 2022-08-24 | -$1.07M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-06-30 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | -$4.62M derived: sum of 2 quarters · filed 2022-08-24 | -$3.21M derived: sum of 3 quarters · filed 2022-08-24 | -$3.71M 10-K · filed 2022-08-24 |
| 2020-03-31 | -$5.70M 10-Q · filed 2021-05-07 | -$4.29M derived: sum of 2 quarters · filed 2021-05-07 | -$4.80M 10-Q · filed 2021-05-07 | -$8.57M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-12-31 | $1.41M 10-Q · filed 2021-02-08 | $904.00K 10-Q · filed 2021-02-08 | -$2.86M derived: sum of 3 quarters · filed 2021-08-25 | -$4.72M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-09-30 | -$504.00K 10-Q · filed 2020-11-09 | -$4.27M derived: sum of 2 quarters · filed 2021-08-25 | -$6.13M derived: sum of 3 quarters · filed 2021-08-25 | -$10.04M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-06-30 | -$3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | -$5.62M derived: sum of 2 quarters · filed 2021-08-25 | -$9.54M derived: sum of 3 quarters · filed 2021-08-25 | -$9.54M 10-K · filed 2021-08-25 |
| 2019-03-31 | -$1.85M 10-Q · filed 2020-05-11 | -$5.77M derived: sum of 2 quarters · filed 2020-05-11 | -$5.77M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | -$3.92M 10-Q · filed 2020-02-06 | -$3.92M 10-Q · filed 2020-02-06 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $0.00 10-K · filed 2020-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |